Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation.

已完结 10 由 Xin 发布于 2025/12/22 14:12:01

DOI:10.2217/pgs.12.185
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.2217/pgs.12.185

Taylor & Francis

Abstract：Hematopoietic stem cell transplantation (HSCT) is a curative treatment for several malignant and nonmalignant disorders. Busulfan (Bu) and cyclophosphamide (Cy) are the most commonly used al

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Self-assembled formation of platinum single atoms and nanoclusters stabilized on MXene as an efficient catalyst for boosting electrocatalytic hydrogen evolution